CN Stock MarketDetailed Quotes

300142 Walvax Biotechnology

Watchlist
  • 13.54
  • -0.80-5.58%
Market Closed Dec 13 15:00 CST
21.66BMarket Cap175.84P/E (TTM)

Walvax Biotechnology Key Stats

EPS
According to the latest financial report of Walvax Biotechnology, the latest earnings per share (TTM) for the company is 0.16. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

BVPS
Analyzing a company's fundamentals? Check out Walvax Biotechnology's latest financial report to see how much their book value per share (BVPS) is currently at 6.00.

Currency: CNY

Cumulative Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Walvax Biotechnology shows that the company's current ratio is 3.10, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Walvax Biotechnology, the quick ratio is 2.72, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

ROE
Want to learn more about the financial health of Walvax Biotechnology? The latest ROE figure is 2.71%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Walvax Biotechnology, the total asset return on investment (ROA) is 2.29%.

Currency: CNY

Cumulative Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Walvax Biotechnology's latest financial report to see how their gross margin is doing - currently at 79.42%.

Currency: CNY

Cumulative Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Walvax Biotechnology, the net profit margin is 16.37%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.